Integra LifeSciences Holdings Gross Profit 2010-2024 | IART

Integra LifeSciences Holdings gross profit from 2010 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Integra LifeSciences Holdings Annual Gross Profit
(Millions of US $)
2024 $882
2023 $885
2022 $970
2021 $945
2020 $851
2019 $953
2018 $901
2017 $753
2016 $643
2015 $556
2014 $494
2013 $417
2012 $516
2011 $481
2010 $464
2009 $438
Integra LifeSciences Holdings Quarterly Gross Profit
(Millions of US $)
2024-12-31 $249
2024-09-30 $200
2024-06-30 $226
2024-03-31 $207
2023-12-31 $226
2023-09-30 $218
2023-06-30 $207
2023-03-31 $233
2022-12-31 $250
2022-09-30 $237
2022-06-30 $249
2022-03-31 $234
2021-12-31 $249
2021-09-30 $242
2021-06-30 $239
2021-03-31 $214
2020-12-31 $242
2020-09-30 $235
2020-06-30 $153
2020-03-31 $221
2019-12-31 $246
2019-09-30 $236
2019-06-30 $240
2019-03-31 $231
2018-12-31 $237
2018-09-30 $223
2018-06-30 $229
2018-03-31 $213
2017-12-31 $220
2017-09-30 $177
2017-06-30 $183
2017-03-31 $172
2016-12-31 $170
2016-09-30 $161
2016-06-30 $160
2016-03-31 $152
2015-12-31 $151
2015-09-30 $140
2015-06-30 $137
2015-03-31 $127
2014-12-31 $93
2014-09-30 $124
2014-06-30 $144
2014-03-31 $133
2013-12-31 $45
2013-09-30 $131
2013-06-30 $124
2013-03-31 $117
2012-12-31 $133
2012-09-30 $131
2012-06-30 $132
2012-03-31 $122
2011-12-31 $121
2011-09-30 $124
2011-06-30 $120
2011-03-31 $116
2010-12-31 $123
2010-09-30 $117
2010-06-30 $114
2010-03-31 $109
2009-12-31 $120
2009-09-30 $109
2009-06-30 $106
2009-03-31 $103
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.222B $1.611B
Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products.
Stock Name Country Market Cap PE Ratio
Intuitive Surgical (ISRG) United States $171.942B 78.88
Thermo Fisher Scientific (TMO) United States $161.378B 19.56
Alcon (ALC) Switzerland $45.645B 30.34
Edwards Lifesciences (EW) United States $42.050B 27.30
IDEXX Laboratories (IDXX) United States $33.347B 38.56
DexCom (DXCM) United States $26.887B 41.56
IQVIA Holdings (IQV) United States $25.374B 14.04
STERIS (STE) Ireland $21.834B 24.97
Mettler-Toledo (MTD) United States $20.944B 24.42
Waters (WAT) United States $19.099B 27.04
SONOVA HOLDING (SONVY) Switzerland $17.304B 0.00
Fresenius Medical Care AG KGaA (FMS) Germany $13.878B 14.16
Hologic (HOLX) United States $12.916B 13.94
Sysmex ADR (SSMXY) Japan $11.847B 0.00
Penumbra (PEN) United States $10.729B 96.64
Globus Medical (GMED) United States $9.767B 22.61
Masimo (MASI) United States $8.221B 34.50
Teleflex (TFX) United States $6.004B 9.24
Glaukos (GKOS) United States $5.153B 0.00
Integer Holdings (ITGR) United States $4.081B 22.07
TransMedics (TMDX) United States $2.985B 87.37
PROCEPT BioRobotics (PRCT) United States $2.907B 0.00
Veracyte (VCYT) United States $2.427B 43.86
Nihon Kohden (NHNKY) Japan $2.081B 11.37
LivaNova (LIVN) United Kingdom $1.934B 11.74
Elekta AB (EKTAY) Sweden $1.891B 17.00
Alphatec Holdings (ATEC) United States $1.522B 0.00
Pulse Biosciences (PLSE) United States $1.193B 0.00
Tandem Diabetes Care (TNDM) United States $1.122B 0.00
Paragon 28 (FNA) United States $1.099B 0.00
Artivion (AORT) United States $0.979B 91.72
OPKO Health (OPK) United States $0.954B 0.00
AxoGen (AXGN) United States $0.690B 0.00
IRadimed (IRMD) United States $0.658B 34.51
Mesa Laboratories (MLAB) United States $0.609B 13.30
SiBone (SIBN) United States $0.588B 0.00
RxSight (RXST) United States $0.584B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.572B 9.21
OrthoPediatrics (KIDS) United States $0.510B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.508B 0.00
Beta Bionics (BBNX) United States $0.483B 0.00
Treace Medical Concepts (TMCI) United States $0.406B 0.00
Delcath Systems (DCTH) United States $0.389B 0.00
AngioDynamics (ANGO) United States $0.387B 0.00
NeuroPace (NPCE) United States $0.351B 0.00
Pacific Biosciences Of California (PACB) United States $0.348B 0.00
ClearPoint Neuro (CLPT) United States $0.342B 0.00
Tactile Systems Technology (TCMD) United States $0.315B 16.87
Semler Scientific (SMLR) United States $0.312B 6.62
Neuronetics (STIM) United States $0.247B 0.00
Inogen (INGN) United States $0.183B 0.00
Alpha Tau Medical (DRTS) Israel $0.181B 0.00
908 Devices (MASS) United States $0.168B 0.00
Spectral Diagnostics (EDTXF) Canada $0.165B 0.00
LENSAR (LNSR) United States $0.164B 0.00
CVRx (CVRX) United States $0.163B 0.00
Accuray (ARAY) United States $0.152B 0.00
Sight Sciences (SGHT) United States $0.137B 0.00
Lucid Diagnostics (LUCD) United States $0.110B 0.00
KORU Medical Systems (KRMD) United States $0.104B 0.00
Rapid Micro Biosystems (RPID) United States $0.104B 0.00
Anteris Technologies Global (AVR) Australia $0.104B 0.00
Monogram Orthopaedics (MGRM) United States $0.095B 0.00
Microbot Medical (MBOT) United States $0.087B 0.00
Atossa Genetics (ATOS) United States $0.080B 0.00
InspireMD (NSPR) Israel $0.079B 0.00
Sensus Healthcare (SRTS) United States $0.076B 11.48
Hyperfine (HYPR) United States $0.054B 0.00
Positron (POSC) United States $0.051B 0.00
EDAP TMS S.A (EDAP) France $0.051B 0.00
EnVVeno Medical (NVNO) United States $0.043B 0.00
Baird Medical Investment Holdings (BDMD) $0.037B 0.00
Vicarious Surgical (RBOT) United States $0.032B 0.00
Spectral AI (MDAI) United States $0.031B 0.00
DarioHealth (DRIO) United States $0.031B 0.00
Precision Optics (POCI) United States $0.030B 0.00
Envoy Medical (COCH) United States $0.029B 0.00
Adagio Medical Holdings (ADGM) United States $0.027B 0.00
NexGel (NXGL) United States $0.022B 0.00
Accelerate Diagnostics (AXDX) United States $0.014B 0.00
PAVmed (PAVM) United States $0.012B 0.00
Ekso Bionics Holdings (EKSO) United States $0.012B 0.00
Biosig Technologies (BSGM) United States $0.010B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.007B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
WORK Medical Technology Group (WOK) China $0.006B 0.00
Nanovibronix (NAOV) United States $0.005B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Check-Cap (CHEK) Israel $0.004B 0.00
ReShape Lifesciences (RSLS) United States $0.003B 0.00
ENDRA Life Sciences (NDRA) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Avinger (AVGR) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00